Ho C - Search Results

1

Alternate Pembrolizumab Dosing Interval in Advanced NSCLC with PD-L1 TPS ≥ 50%: 3 Weekly Compared to 6 Weekly Dosing.

Jones L, Rittberg R, Leung B, Shokoohi A, Pender A, Wong S, Al-Hashami Z, Wang Y, Ho C. Jones L, et al. Among authors: ho c. Curr Oncol. 2022 Nov 15;29(11):8686-8692. doi: 10.3390/curroncol29110685. Curr Oncol. 2022. PMID: 36421338 Free PMC article.

2

Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.

Noonan K, Tong KM, Laskin J, Melosky B, Sun S, Murray N, Ho C. Noonan K, et al. Among authors: ho c. Lung Cancer. 2014 Dec;86(3):344-9. doi: 10.1016/j.lungcan.2014.09.016. Epub 2014 Oct 2. Lung Cancer. 2014. PMID: 25439436

3

Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review.

Smoragiewicz M, Laskin J, Wilson D, Ramsden K, Yee J, Lam S, Shaipanich T, Zhai Y, Ho C. Smoragiewicz M, et al. Among authors: ho c. Curr Oncol. 2014 Dec;21(6):e768-74. doi: 10.3747/co.21.2125. Curr Oncol. 2014. PMID: 25489265 Free PMC article.

4

Maintenance chemotherapy in advanced NSCLC: a population-based assessment of eligibility.

Tong KM, Laskin J, Ho C. Tong KM, et al. Among authors: ho c. Lung Cancer. 2015 Mar;87(3):296-302. doi: 10.1016/j.lungcan.2014.12.014. Epub 2015 Jan 5. Lung Cancer. 2015. PMID: 25601487

5

Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified.

Ho C, Tong KM, Ramsden K, Ionescu DN, Laskin J. Ho C, et al. Curr Oncol. 2015 Jun;22(3):e164-70. doi: 10.3747/co.22.2339. Curr Oncol. 2015. PMID: 26089727 Free PMC article.

6

Evaluation of a 'Watch and Wait' Approach for Chemotherapy in Patients with Newly Diagnosed Advanced Non-small Cell Lung Cancer from a Diverse Community Population.

Noonan K, Tong KM, Laskin J, Zheng YY, Melosky B, Sun S, Murray N, Ho C. Noonan K, et al. Among authors: ho c. Clin Oncol (R Coll Radiol). 2015 Sep;27(9):505-13. doi: 10.1016/j.clon.2015.05.009. Epub 2015 Jun 19. Clin Oncol (R Coll Radiol). 2015. PMID: 26095646

7

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials.

Noonan KL, Ho C, Laskin J, Murray N. Noonan KL, et al. Among authors: ho c. J Thorac Oncol. 2015 Nov;10(11):1523-31. doi: 10.1097/JTO.0000000000000667. J Thorac Oncol. 2015. PMID: 26536194 Free article. Review.

8

Radiographic patterns and survival of patients with early and late brain metastases in EGFR wild type and mutant non small cell lung cancer.

Yuan R, Yamada A, Weber B, Ho C. Yuan R, et al. Among authors: ho c. J Neurooncol. 2016 May;127(3):525-33. doi: 10.1007/s11060-016-2057-5. Epub 2016 Jan 16. J Neurooncol. 2016. PMID: 26780337

9

Integration of a nurse navigator into the triage process for patients with non-small-cell lung cancer: creating systematic improvements in patient care.

Zibrik K, Laskin J, Ho C. Zibrik K, et al. Among authors: ho c. Curr Oncol. 2016 Jun;23(3):e280-3. doi: 10.3747/co.23.2954. Epub 2016 Jun 9. Curr Oncol. 2016. PMID: 27330366 Free PMC article.

10

Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations.

Hsu F, De Caluwe A, Anderson D, Nichol A, Toriumi T, Ho C. Hsu F, et al. Among authors: ho c. Curr Oncol. 2017 Aug;24(4):228-233. doi: 10.3747/co.24.3496. Epub 2017 Aug 31. Curr Oncol. 2017. PMID: 28874890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,966 results

Search Page

Filters